Not long ago, when a dog was diagnosed with lymphoma, one of the most common forms of canine cancer, pet guardians had little reason to hope for a cure. With success rates of less than 2% and remission times lasting on average just over 12 months, current chemotherapy protocols have not been able to offer much promise of long term success. But, a new method of treating dogs with lymphoma is changing all of that.
Doctors in the Oncology Service at NC State University’s Veterinary Teaching Hospital are now using bone marrow transplants (BMT) to treat canine patients with lymphoma – a new application of an existing technology responsible for saving the lives of thousands of humans each year. It was the impressive success rate of the VTH Bone Marrow Transplant Unit that convinced Kristie and Johnny Sullens that a BMT was the best chance of saving their dog Angel’s life.
Learn about Angel’s experience and the CVM Bone Marrow Transplant Program through Georgia’s Legacy, a Canine Cancer Blog.
Angel poses with Dr. Catherine Garon from Riverlands Hospital in LaPlace, LA, where she received the treatment necessary prior to the bone marrow transplant procedure at the NC State University Veterinary Teaching Hospital.
Dr. Steve Suter discusses the NC State University Canine Bone Marrow Transplant Program and related CVM oncology research.